Characteristics of Endoret®(prgf®) technology

Tubo de ensayo

  • It is simple as it requires just one centrifugation On the other hand, other technologies use several centrifugations, which can cause the nonspecific activation of platelets..
  • The volume of blood used is variable (from 9ml) and adequate for each application. Endoret®(prgf®) technology is the most efficient technology in the market to obtain plasma..
  • It is precise because it allows you to control the moment the plasma is activated..
  • It uses concentrations of growth factors within the therapeutic window for the stimulation of tissue regeneration as has been demonstrated in in-vitro research, in animals or in clinical trials. Other products use concentrations outside this window, obtaining unpredictable results.
  • 100% biocompatible, safe and versatile
  • It does not include leucocytes in its formulation, thus avoiding their proinflammatory effects.

Intended for international use only. Indications for use of products and/or therapies contained herein may not be cleared /approved for use by the following Health international agencies: US Food & Drug Administration, Health Canada or Japanese Health Ministry. To access the specific information of your market, use the country selector located on the top menu of this page.

Are you interested in contacting us?